ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $247,000 | -67.8% | 1,433 | -76.5% | 0.01% | -70.0% |
| Q2 2021 | $766,000 | +978.9% | 6,110 | +1070.5% | 0.02% | +1900.0% |
| Q1 2021 | $71,000 | -92.8% | 522 | -93.2% | 0.00% | -96.7% |
| Q4 2020 | $985,000 | +598.6% | 7,698 | +512.4% | 0.03% | +1400.0% |
| Q3 2020 | $141,000 | -90.0% | 1,257 | -91.5% | 0.00% | -96.6% |
| Q2 2020 | $1,405,000 | +2028.8% | 14,747 | +1092.2% | 0.06% | +1060.0% |
| Q4 2019 | $66,000 | +842.9% | 1,237 | +554.5% | 0.01% | – |
| Q3 2019 | $7,000 | -92.1% | 189 | -91.2% | 0.00% | -100.0% |
| Q2 2019 | $89,000 | +4350.0% | 2,160 | +7900.0% | 0.01% | – |
| Q3 2018 | $2,000 | -96.6% | 27 | -98.2% | 0.00% | -100.0% |
| Q1 2018 | $59,000 | +145.8% | 1,500 | +164.6% | 0.01% | +66.7% |
| Q4 2017 | $24,000 | +26.3% | 567 | +12.9% | 0.00% | +50.0% |
| Q3 2017 | $19,000 | +533.3% | 502 | +402.0% | 0.00% | – |
| Q2 2017 | $3,000 | -88.0% | 100 | -89.9% | 0.00% | -100.0% |
| Q4 2016 | $25,000 | -19.4% | 993 | +14.9% | 0.00% | 0.0% |
| Q3 2016 | $31,000 | +3000.0% | 864 | +4220.0% | 0.00% | – |
| Q1 2016 | $1,000 | -95.5% | 20 | -97.7% | 0.00% | -100.0% |
| Q3 2015 | $22,000 | -31.2% | 873 | +5.1% | 0.00% | -50.0% |
| Q1 2015 | $32,000 | – | 831 | +41450.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 2 | -99.9% | 0.00% | -100.0% |
| Q2 2014 | $89,000 | +48.3% | 2,624 | +51.3% | 0.01% | +37.5% |
| Q1 2014 | $60,000 | +9.1% | 1,734 | +23.9% | 0.01% | -11.1% |
| Q4 2013 | $55,000 | – | 1,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |